THE USE OF RISPERIDONE AMONG INDIVIDUALS WITH MENTAL RETARDATION: CLINICALLY SUPPORTED OR NOT?
Saved in:
SINGH, A.N., ET AL., THE USE OF RISPERIDONE AMONG INDIVIDUALS WITH MENTAL RETARDATION: CLINICALLY SUPPORTED OR NOT?. Research in Developmental Disabilities, Vol. 26, no. 3 (2005), p. 203-218.
Ref.
132292
Location:
SIIS R.775 Archivo
Palabras clave:
Discapacidad intelectual, Efectos, Evaluación de servicios, Fármacos, Literatura científica, Psicótropos, Trastornos de la conducta, Tratamiento médico
Discapacidad intelectual, Efectos, Evaluación de servicios, Fármacos, Literatura científica, Psicótropos, Trastornos de la conducta, Tratamiento médico
Similar Items: THE USE OF RISPERIDONE AMONG INDIVIDUALS WITH MENTAL RETARDATION: CLINICALLY SUPPORTED OR NOT?
- SUBSTITUTING TRADITIONAL ANTIPSYCHOTICS WITH RISPERIDONE FOR INDIVIDUALS WITH MENTAL RETARDATION
- PSYCHOPHARMACOLOGY AND MENTAL RETARDATION: A 10 YEAR REVIEW (1990-1999).
- PSYCHOTROPIC MEDICATION USE FOR CHALLENGING BEHAVIORS IN PERSONS WITH INTELLECTUAL DISABILITIES: AN OVERVIEW
- SUBSTITUTING TRADITIONAL ANTIPSYCHOTICS WITH RISPERIDONE FOR INDIVIDUALS WITH MENTAL RETARDATION
- EFFECTS OF CLOZAPINE ON SELF-INJURIOUS BEHAVIOR OF TWO RISPERIDONE NONRESPONDERS WITH MENTAL RETARDATION
- GUIDELINES FOR THE USE OF PSYCHOTROPIC MEDICATION IN INDIVIDUALS WITH DEVELOPMENTAL DISABILITIES